CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,539 | +3891.4% | 45,509 | +708.6% | 0.00% | – |
| Q2 2022 | $17,000 | -26.1% | 5,628 | -22.4% | 0.00% | – |
| Q1 2022 | $23,000 | -8.0% | 7,256 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | +13.6% | 7,256 | +20.6% | 0.00% | – |
| Q3 2021 | $22,000 | -15.4% | 6,015 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -3.7% | 6,015 | 0.0% | 0.00% | – |
| Q1 2021 | $27,000 | +35.0% | 6,015 | +71.9% | 0.00% | – |
| Q4 2020 | $20,000 | -20.0% | 3,500 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |